PMV Pharmaceuticals, Inc. (PMVP) stock
PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.22+0.03 (+2.52%)
Close on Nov 17, 2026Market cap $65.22MP/E –Yield –
PMV Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PMV Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$71.27M. For fiscal 2025 it was -$73.58M. The highest annual figure on record is -$15.18M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$73.58M | – |
| FY2024 | Dec 31, 2024 | -$51.28M | – |
| FY2023 | Dec 31, 2023 | -$55.66M | – |
| FY2022 | Dec 31, 2022 | -$63.76M | – |
| FY2021 | Dec 31, 2021 | -$46.57M | – |
| FY2020 | Dec 31, 2020 | -$32.74M | – |
| FY2019 | Dec 31, 2019 | -$22.07M | – |
| FY2018 | Dec 31, 2018 | -$15.18M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$19.68M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.19M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.30M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.66M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.84M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.60M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.18M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.09M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.32M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.76M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.68M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.40M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.24M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.90M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.39M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.90M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.13M | – |
See a number that looks wrong?